Cytek Biosciences
Stock Forecast, Prediction & Price Target
Cytek Biosciences Financial Estimates
Cytek Biosciences Revenue Estimates
Cytek Biosciences EBITDA Estimates
Cytek Biosciences Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | ||
Revenue
% change YoY
| $127.95M N/A | $164.03M 28.20% | $193.01M 17.66% | Avg: $247.47M Low: $238.25M High: $256.16M avg. 28.21% | Avg: $278.59M Low: $268.03M High: $288.64M avg. 12.57% | ||
Net Income
% change YoY
| $4.41M N/A | $2.57M -41.67% | $-12.14M -571.58% | Avg: $3.40M Low: $-2.70M High: $24.35M avg. 127.99% | Avg: $12.11M Low: $9.46M High: $18.93M avg. 256.22% | ||
EBITDA
% change YoY
| $7.68M N/A | $3.83M -50.14% | $-4.40M -215.00% | Avg: $11.38M Low: $10.96M High: $11.78M avg. 358.26% | Avg: $12.81M Low: $12.33M High: $13.27M avg. 12.57% | ||
EPS
% change YoY
| $0.03 N/A | $0.02 -41.81% | -$0.09 -567.70% | Avg: $0.06 Low: -$0.02 High: $0.18 avg. 171.26% | Avg: $0.11 Low: $0.07 High: $0.14 avg. 66.67% | ||
Operating Expenses
% change YoY
| $69.97M N/A | $102.77M 46.87% | $137.27M 33.56% | Avg: $89.10M Low: $85.78M High: $92.23M avg. -35.08% | Avg: $100.31M Low: $96.51M High: $103.93M avg. 12.57% | ||
FAQ
What is Cytek Biosciences stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 192.11% in 2025-2026.
We have gathered data from 4 analysts. Their low estimate is -2.70M, average is 3.40M and high is 24.35M.
What is Cytek Biosciences stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 20.39% in 2025-2026.
We have gathered data from 5 analysts. Their low revenue estimate is $238.25M, average is $247.47M and high is $256.16M.
What is Cytek Biosciences stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 118.97% in 2025-2026.
We have gathered data from 4 analysts. Their low earnings per share estimate is -$0.02, average is $0.06 and high is $0.18.
What is the best performing analyst?
In the last twelve months analysts have been covering Cytek Biosciences stock. The most successful analyst is Dave Westenberg.